Abstract
The JTpeak interval has been proposed as a new biomarker to demonstrate mixed ion channel effects, potentially leading to reduced late-stage electrocardiogram (ECG) monitoring for mildly QT-prolonging drugs. ECG waveforms from the IQ-CSRC study were used. Twenty healthy subjects were enrolled with 6 subjects on placebo and 9 subjects on each of 5 mildly QT-prolonging drugs - moxifloxacin, dofetilide, ondansetron, dolasetron, and quinine - and 1 negative drug, levocetirizine. A vector magnitude lead was derived from 12-lead ECGs, and measurements were made on a median beat from three 10-second replicates. Data were analyzed using a linear concentration-response model with QTcF and heart rate corrected JTpeak (JTpeak_c) as dependent variables. For moxifloxacin, dofetilide, and ondansetron, all pure hERG blockers, slopes of the concentration (C)-QTcF and C-JTpeak_c relationships were positive and statistically significant. With the prespecified linear model, the predicted effects on ΔΔQTcF and ΔΔJTpeak_c were 11.4 and 9.4 milliseconds for moxifloxacin at the geometric mean Cmax on day 1, 9.0 and 11.7 milliseconds for dofetilide and 11.5, and 7.9 milliseconds for ondansetron, respectively. In contrast, dolasetron and quinine, both ...Continue Reading
References
Aug 11, 2001·European Journal of Clinical Pharmacology·F De PontiN Montanaro
Jul 12, 2002·Drugs·Peter M Haddad, Ian M Anderson
Apr 20, 2004·Journal of Cardiovascular Electrophysiology·Robert R FenichelUNKNOWN Independent Academic Task Force
Mar 18, 2011·Analytical Chemistry·B H IsselhardtS G Prussin
Jul 3, 2013·Scientific Reports·James KramerArthur M Brown
Dec 18, 2013·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Jan 1, 2014·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Borje DarpoNorman Stockbridge
Mar 1, 2014·American Heart Journal·Philip T SagerNorman Stockbridge
Jul 24, 2014·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Sep 1, 2014·American Heart Journal·Borje DarpoRobert Wallis
Feb 12, 2015·Clinical Pharmacology and Therapeutics·B DarpoN Stockbridge
Apr 15, 2015·Journal of the American Heart Association·Jose VicenteDavid G Strauss
Jul 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Borje DarpoNorman Stockbridge
Aug 12, 2015·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Apr 10, 2016·Journal of Pharmacological and Toxicological Methods·William J CrumbDavid G Strauss
Dec 31, 2016·PloS One·Lars JohannesenDavid G Strauss
Feb 17, 2017·Circulation. Arrhythmia and Electrophysiology·Zhihua LiThomas Colatsky
Feb 18, 2017·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Yuka TakeuchiTadayoshi Hata
Sep 19, 2017·Journal of Electrocardiology·Jay W Mason
Sep 21, 2017·Journal of Electrocardiology·Jose VicenteDavid G Strauss
Oct 8, 2017·Clinical Pharmacology and Therapeutics·Jose VicenteDavid G Strauss
Oct 13, 2017·Journal of Electrocardiology·Jean-Philippe CoudercMathias Baumert
Dec 7, 2017·Journal of Pharmacokinetics and Pharmacodynamics·Christine GarnettYaning Wang
Jul 1, 2018·Journal of Pharmacological and Toxicological Methods·Rob WallisJean-Pierre Valentin
Nov 11, 2018·Clinical and Translational Science·Marina BrockwayBrian P Brockway
Nov 18, 2018·Clinical Pharmacology and Therapeutics·Jose VicenteDavid G Strauss
Mar 26, 2019·Journal of Clinical Pharmacology·Jose VicenteRobert Noveck
Citations
Dec 18, 2020·Clinical Pharmacology and Therapeutics·David G StraussChristine Garnett
May 20, 2021·Journal of Clinical Pharmacology·Rajesh Krishna
Jul 3, 2021·Journal of Clinical Pharmacology·Mark G MideiA John Camm
Apr 26, 2021·Journal of Clinical Pharmacology·Borje Darpo, Georg Ferber